Solriamfetol 150 mg Oral Tablet
JZP110-401
Phase 1 small_molecule completed
Quick answer
Solriamfetol 150 mg Oral Tablet for Narcolepsy is a Phase 1 program (small_molecule) at Axsome Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Axsome Therapeutics
- Indication
- Narcolepsy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed